PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents

Kiran M. Kanth, Guillermo E. Solorzano, Myla D. Goldman

Research output: Contribution to journalArticle

20 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)e17-e19
JournalNeurology: Clinical Practice
Volume6
Issue number2
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

Fingerprint

Myasthenia Gravis

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents. / Kanth, Kiran M.; Solorzano, Guillermo E.; Goldman, Myla D.

In: Neurology: Clinical Practice, Vol. 6, No. 2, 01.04.2016, p. e17-e19.

Research output: Contribution to journalArticle

Kanth, Kiran M. ; Solorzano, Guillermo E. ; Goldman, Myla D. / PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents. In: Neurology: Clinical Practice. 2016 ; Vol. 6, No. 2. pp. e17-e19.
@article{3d05529ff6ef44dfa00364ebe8a23eec,
title = "PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents",
author = "Kanth, {Kiran M.} and Solorzano, {Guillermo E.} and Goldman, {Myla D.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1212/CPJ.0000000000000202",
language = "English (US)",
volume = "6",
pages = "e17--e19",
journal = "Neurology: Clinical Practice",
issn = "2163-0402",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents

AU - Kanth, Kiran M.

AU - Solorzano, Guillermo E.

AU - Goldman, Myla D.

PY - 2016/4/1

Y1 - 2016/4/1

UR - http://www.scopus.com/inward/record.url?scp=84962728170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962728170&partnerID=8YFLogxK

U2 - 10.1212/CPJ.0000000000000202

DO - 10.1212/CPJ.0000000000000202

M3 - Article

AN - SCOPUS:84962728170

VL - 6

SP - e17-e19

JO - Neurology: Clinical Practice

JF - Neurology: Clinical Practice

SN - 2163-0402

IS - 2

ER -